Tag Archives: Corcept Therapeutics

The CBO of Corcept Therapeutics (NASDAQ: CORT) is Selling Shares

Yesterday, the CBO of Corcept Therapeutics (CORT – Research Report), Gary Charles Robb, sold shares of CORT for $1.13M. See today’s analyst top recommended stocks >> Based on Corcept Therapeutics’ latest earnings report for the quarter ending June 30, the

Analysts Offer Insights on Healthcare Companies: Corcept Therapeutics (NASDAQ: CORT), Ligand Pharma (NASDAQ: LGND) and Seagen (NASDAQ: SGEN)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Corcept Therapeutics (CORT – Research Report), Ligand Pharma (LGND – Research Report) and Seagen (SGEN – Research Report) with bullish sentiments. Corcept

A Director at Corcept Therapeutics is Exercising Options

Yesterday it was reported that a Director at Corcept Therapeutics (CORT – Research Report), Leonard G. Baker, exercised options to buy 150,000 CORT shares at $3.70 a share, for a total transaction value of $555K. The options were close to

A Director at Corcept Therapeutics (NASDAQ: CORT) is Buying Shares

Yesterday, a Director at Corcept Therapeutics (CORT – Research Report), Leonard G. Baker, bought shares of CORT for $577.5K. See today’s analyst top recommended stocks >> Based on Corcept Therapeutics’ latest earnings report for the quarter ending June 30, the